 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
: i7 ]: }7 A$ s4 C$ X + }" n* I* D4 d' q" K
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.6 R6 I1 ~! a e
6 c& F1 [8 Y4 I- r1 j: I+ Q% eBY THE EDMONTON JOURNAL FEBRUARY 16, 2007
' W5 E: S+ F4 T# v: f- n
, v/ [( Q( S1 i7 C9 N8 z1 B8 Y/ \' a & h/ E8 `/ Q' C! S$ K0 |$ ^9 ?
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX. R" T6 f% c* a+ o& S0 I2 G
% G* u/ O* c! ^$ }( HThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
2 P+ O" c* B1 B- b+ P+ X! s/ C; i4 g- m. h$ N# Q
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
; J8 y3 D! _' a4 _6 H" n+ V7 J
# p0 c: U2 j9 U; a7 NIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
! r9 t0 @. r5 J+ {/ ^5 T1 L# a# \- Z" t* D0 x4 C$ Q1 p5 z
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
! d9 ]: b! v6 d
3 o. [' c6 |2 v' Q; b# T# j"As a scientist, it's one of the highlights of my CAREER," Shan said.
, V( j1 {0 m. ~/ ~9 e$ {
`- x0 Z% h$ X"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."0 z9 u5 M0 q" }
) h/ _; t7 s7 V9 VIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.0 u/ Y: i( y7 ~! [$ t* Y) O1 _
- L4 E H5 j; w' Q! H, Q& ~
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
6 t7 U+ x" M" P! v M6 I: d" D" u6 ~3 n3 E. y; k1 A" Q
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.9 F: W$ j; e: n- X
- }3 Q. R/ E9 ^9 @( C$ c3 X8 ^+ a+ S3 X( T
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
2 `' ]. ^$ C( D' Q" X+ f$ A! V
发表于 2015-2-28 19:45
